RJB-0402

N/A

Report date: 2024/05/09 11:52:21

Base Information

Drug NameRJB-0402
Drug Alias NameRJB-0402
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionFibroblast growth factor 21 agonists
TargetsFibroblast growth factor 21
Therapy Area/IndicationsLipodystrophy, Familial PartialCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRejuvenate Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesRejuvenate Bio Inc
Inactive CompaniesN/A
Active IndicationsLipodystrophy, Familial PartialCardiomyopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A